Name: 유럽 수면 장애 치료 시장 – 2028년까지의 산업 동향 및 예측
Brand: Data Bridge Market Research
SKU: 59667
Price: 3500.00 USD
Availability: InStock
Rating: 4.5 (51 reviews)

>유럽 수면 장애 치료 시장, 유형별(불면증, 수면 무호흡증, 불안 다리 증후군(RLS), 기면증 및 기타), 치료(약물 치료, 기계적 치료, 하악 전진 장치, 설하 신경 자극기, 수술 및 기타) 투여 경로(경구, 비경구 및 기타), 약물 유형(브랜드 및 제네릭), 인구 유형(어린이 및 성인), 최종 사용자(병원, 전문 병원, 가정 의료, 외래 수술 센터 및 기타), 유통 채널(직접 입찰, 병원 약국, 소매 약국, 온라인 약국 및 기타), 국가(영국, 독일, 프랑스, 헝가리, 리투아니아, 오스트리아, 아일랜드, 노르웨이, 폴란드, 터키, 스페인, 이탈리아, 네덜란드, 스위스, 러시아 및 유럽의 나머지 지역) 산업 동향 및 2028년까지의 예측

시장 분석 및 통찰력: 유럽 수면 장애 치료 시장

수면 장애 치료 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 7.6%의 CAGR로 성장하고 있으며 2028년까지 2,849.03백만 달러에 도달할 것으로 예상한다고 분석합니다. 유럽 수면 장애 치료 시장은 전 세계적으로 수면 무호흡증, 불면증, 기면증과 같은 수면 장애의 유병률이 증가함에 따라 성장할 것으로 예상됩니다.

수면 무호흡증 , 기면증 또는 불면증 과 같은 수면 장애 는 환자가 수면 유지 또는 수면 시작에 어려움을 겪는 의학적 장애입니다. 이 장애는 불규칙한 정신적, 신체적, 사회적 및 정서적 기능을 유발합니다. 수면 장애는 환자의 증상에 따라 다양한 치료 옵션을 통해 치료됩니다. 대부분의 수면 무호흡증 환자는 기계적 치료를 통해 치료됩니다.

수면 장애의 증가는 수면 장애 치료 옵션에 대한 수요를 증가시킬 것입니다. 따라서 바쁜 삶과 건강에 해로운 습관으로 인한 정신적 스트레스의 증가는 수면 장애 치료 시장의 성장을 촉진할 것으로 예상됩니다. 부작용의 정도는 생명을 위협할 수 있어 환자에게 소비에 대한 두려움을 유발할 수 있으므로 판매와 수요가 감소합니다. 따라서 약물 의 부작용은 수면 장애 치료 시장 성장을 억제하는 요인으로 작용합니다. 증가하는 기술 발전은 수면 장애 치료 시장 수요를 촉진하는 기회로 작용하고 있습니다. 수면 장애 치료의 높은 비용은 수면 장애 치료 시장 성장에 도전으로 작용합니다.

수면 장애 치료 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 수면 장애 치료 시장 시나리오를 이해하려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 요청하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.

수면 장애 치료 시장 범위 및 시장 규모

수면 장애 치료 시장은 유형, 치료, 투여 경로, 약물 유형, 인구 유형, 최종 사용자 및 유통 채널을 기준으로 하는 7개의 주요 세그먼트로 분류됩니다. 세그먼트 간의 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.

수면 장애 치료 시장은 유형에 따라 불면증 , 수면 무호흡증, 불안 다리 증후군(RLS), 기면증 및 기타로 세분화됩니다. 2021년에는 불면증 부문이 특정 장애에 대한 혁신적인 치료 옵션을 개발하기 위한 기술 발전으로 인해 수면 장애 치료 시장을 지배할 것으로 예상됩니다.
치료를 기준으로 수면 장애 치료 시장은 약물 치료, 기계적 치료, 하악 전진 장치, 설하 신경 자극기, 수술 및 기타로 세분화됩니다. 2021년에는 약물 치료 부문이 수면 장애 치료 시장을 지배할 것으로 예상되는데, 환자의 증상에 따라 수면 장애를 치료하는 데 사용할 수 있는 다양한 종류의 약물이 있기 때문입니다.
투여 경로에 따라 수면 장애 치료 시장은 경구, 비경구 및 기타로 세분화됩니다. 2021년에는 졸음증, 불안 다리 증후군(RLS) 및 불면증과 같은 수면 장애 치료를 위한 경구 약물의 가용성이 증가함에 따라 경구 세그먼트가 수면 장애 치료 시장을 지배할 것으로 예상됩니다.
약물 유형에 따라 수면 장애 치료 시장은 브랜드 와 제네릭으로 구분됩니다. 2021년에는 가바펜틴, 졸피뎀 ER 정제, 에스조피클론 정제, CIV 등 수면 장애 치료를 위한 제네릭 약물의 가용성이 증가함에 따라 제네릭 세그먼트가 수면 장애 치료 시장을 지배할 것으로 예상됩니다.
인구 유형에 따라 수면 장애 치료 시장은 어린이와 성인으로 세분화됩니다. 2021년에는 전 세계적으로 노인 인구가 급증하면서 더욱 진보된 치료 옵션이 필요하기 때문에 성인 세그먼트가 수면 장애 치료 시장을 지배할 것으로 예상됩니다.
최종 사용자를 기준으로 수면 장애 치료 시장은 병원 , 전문 병원, 가정 의료, 외래 수술 센터 등으로 세분화됩니다. 2021년에는 병원 부문이 수술에 사용되는 값비싼 장비를 구매할 수 있는 병원의 재정적 능력과 기계 장치와 처방된 약물을 작동할 수 있는 숙련된 전문가의 존재로 인해 수면 장애 치료 시장을 지배할 것으로 예상됩니다.
유통 채널을 기준으로 수면 장애 치료 시장은 직접 입찰, 병원 약국, 소매 약국, 온라인 약국 등으로 세분화됩니다. 2021년에는 대부분의 약물이 직접 입찰 서비스를 통해 조달되기 때문에 직접 입찰 부문이 수면 장애 치료 시장을 지배할 것으로 예상됩니다.

수면 장애 치료 시장 국가 수준 분석

수면 장애 치료 시장을 분석하고, 위에 언급된 대로 국가, 유형, 치료, 투여 경로, 약물 유형, 인구 유형, 최종 사용자 및 유통 채널별로 시장 규모 정보를 제공합니다.

유럽 수면 장애 치료 시장 보고서에서 다루는 국가는 영국, 독일, 프랑스, 헝가리, 리투아니아, 오스트리아, 아일랜드, 노르웨이, 폴란드, 터키, 스페인, 이탈리아, 네덜란드, 스위스, 러시아 및 기타 유럽 국가입니다.

유럽 수면 장애 치료 시장에서는 독일이 수면 장애 유병률이 증가하고, 노령 인구가 증가함에 따라 수면 장애 치료 시장이 확대되면서 시장을 장악하고 있습니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 유럽 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

제조업체의 신제품 출시로 수면 장애 치료 시장 참여자들에게 새로운 기회가 창출되고 있습니다.

수면 장애 치료 시장은 또한 수면 장애 치료 시장 판매와 함께 미용 산업의 모든 국가적 성장에 대한 자세한 시장 분석, 수면 장애 치료 시장 발전의 영향, 수면 장애 치료 시장에 대한 지원과 함께 규제 시나리오의 변화를 제공합니다. 이 데이터는 2010년부터 2019년까지의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 수면 장애 치료 시장 점유율 분석

수면 장애 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선입니다. 위에 제공된 데이터 포인트는 수면 장애 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

보고서에서 다루는 수면 장애 치료 시장의 주요 업체는 Jazz Pharmaceuticals, Inc., Pfizer Inc., Viatris Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Taj Pharmaceuticals Limited, Eli Lilly and Company, Mallinckrodt, Alembic Pharmaceuticals Limited, Dr. Reddy's Laboratories Ltd., Taro Pharmaceutical Industries Ltd., Koninklijke Philips NV, DeVilbiss Healthcare LLC, ResMed, SomnoMed 등입니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

또한 전 세계 여러 회사에서 많은 제품 출시와 계약을 체결하면서 수면 장애 치료 시장도 활성화되고 있습니다.

예를 들어,

2019년 11월, Pfizer, Inc.는 Upjohn이라는 사업부가 Mylan NV와 결합되어 Viatris라는 새로운 회사를 만들었다고 발표했습니다. 이 회사의 사업부와 Mylan NV의 결합으로 제품 포트폴리오가 늘어나 시장에서 제품 수요가 증가했습니다.

시장 참여자의 협력, 합작투자 및 기타 전략은 수면 장애 치료 시장에서 회사 시장을 강화하고 있으며, 이를 통해 조직이 수면 장애 치료에 대한 제공 사항을 개선하는 데에도 도움이 됩니다.

SKU-59667

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Click on image to enlarge

대화형 데이터 분석 대시보드
높은 성장 잠재력 기회를 위한 회사 분석 대시보드
사용자 정의 및 질의를 위한 리서치 분석가 액세스
대화형 대시보드를 통한 경쟁자 분석
최신 뉴스, 업데이트 및 추세 분석
포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용

데모 요청

표 목록

LIST OF TABLES

TABLE 1 EUROPE SLEEP DISORDER TREATMENT MARKET: PIPELINE ANALYSIS

TABLE 2 GENERIC DRUGS FOR SLEEP DISORDER TREATMENT

TABLE 3 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 4 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 5 EUROPE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 6 EUROPE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 7 EUROPE SLEEP SPNEA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 8 EUROPE RESTLESS LEGS SYNDROME (RLS) IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 9 EUROPE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 10 EUROPE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 11 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT, 2018-2028 (USD MILLION)

TABLE 12 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 13 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 14 EUROPE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 15 EUROPE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 16 EUROPE MANDIBULAR ADVANCEMENT DEVICES IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 17 EUROPE HYPOGLOSSAL NERVE STIMULATOR IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 18 EUROPE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 19 EUROPE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 20 EUROPE OTHERS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 21 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 22 EUROPE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 23 EUROPE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 24 EUROPE PARENTERAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 25 EUROPE OTHERS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 26 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 27 EUROPE GENERICS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 28 EUROPE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 29 EUROPE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 30 EUROPE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE, 2018-2028 (USD MILLION)

TABLE 31 EUROPE ADULT IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 32 EUROPE CHILDREN IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 33 EUROPE SLEEP DISORDER TREATMENT MARKET, BY END USER, 2018-2028 (USD MILLION)

TABLE 34 EUROPE HOSPITALS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 35 EUROPE SPECIALTY CLINICS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 36 EUROPE HOME HEALTHCARE IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 37 EUROPE AMBULATORY SURGICAL CENTER IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 38 EUROPE OTHERS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 39 EUROPE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2028 (USD MILLION)

TABLE 40 EUROPE DIRECT TENDER IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 41 EUROPE HOSPITAL PHARMACY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 42 EUROPE RETAIL PHARMACY IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 43 EUROPE ONLINE PHARMACY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 44 EUROPE HOSPITALS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 45 EUROPE SLEEP DISORDER TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 46 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 EUROPE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 EUROPE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 49 EUROPE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 50 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 51 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 52 EUROPE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 53 EUROPE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 54 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 55 EUROPE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 56 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 57 EUROPE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 58 EUROPE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 59 EUROPE SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 60 EUROPE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 61 GERMANY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 62 GERMANY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 63 GERMANY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 64 GERMANY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 65 GERMANY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 66 GERMANY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 67 GERMANY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 68 GERMANY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 69 GERMANY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 70 GERMANY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 71 GERMANY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 72 GERMANY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 73 GERMANY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 74 GERMANY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 75 GERMANY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 76 FRANCE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 77 FRANCE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 FRANCE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 79 FRANCE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 80 FRANCE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 81 FRANCE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 82 FRANCE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 83 FRANCE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 84 FRANCE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 85 FRANCE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 86 FRANCE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 87 FRANCE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 88 FRANCE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 89 FRANCE SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 90 FRANCE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 91 U.K. SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 92 U.K. INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 93 U.K. SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 94 U.K. NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 95 U.K. SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 96 U.K. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 97 U.K. MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 98 U.K. SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 99 U.K. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 100 U.K. ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 101 U.K. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 102 U.K. BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 103 U.K. SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 104 U.K. SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 105 U.K. SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 106 ITALY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 107 ITALY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 108 ITALY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 109 ITALY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 110 ITALY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 111 ITALY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 112 ITALY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 113 ITALY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 114 ITALY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 115 ITALY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 116 ITALY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 117 ITALY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 118 ITALY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 119 ITALY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 120 ITALY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 121 SPAIN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 122 SPAIN INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 123 SPAIN SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 124 SPAIN NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 125 SPAIN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 126 SPAIN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 127 SPAIN MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 128 SPAIN SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 129 SPAIN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 130 SPAIN ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 131 SPAIN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 132 SPAIN BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 133 SPAIN SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 134 SPAIN SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 135 SPAIN SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 136 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 137 RUSSIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 138 RUSSIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 139 RUSSIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 140 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 141 RUSSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 142 RUSSIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 143 RUSSIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 144 RUSSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 145 RUSSIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 146 RUSSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 147 RUSSIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 148 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 149 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 150 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 151 IRELAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 152 IRELAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 153 IRELAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 154 IRELAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 155 IRELAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 156 IRELAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 157 IRELAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 158 IRELAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 159 IRELAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 160 IRELAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 161 IRELAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 162 IRELAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 163 IRELAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 164 IRELAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 165 IRELAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 166 NORWAY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 167 NORWAY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 168 NORWAY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 169 NORWAY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 170 NORWAY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 171 NORWAY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 172 NORWAY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 173 NORWAY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 174 NORWAY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 175 NORWAY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 176 NORWAY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 177 NORWAY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 178 NORWAY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 179 NORWAY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 180 NORWAY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 181 POLAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 182 POLAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 183 POLAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 184 POLAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 185 POLAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 186 POLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 187 POLAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 188 POLAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 189 POLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 190 POLAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 191 POLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 192 POLAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 193 POLAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 194 POLAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 195 POLAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 196 TURKEY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 197 TURKEY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 198 TURKEY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 199 TURKEY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 200 TURKEY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 201 TURKEY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 202 TURKEY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 203 TURKEY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 204 TURKEY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 205 TURKEY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 206 TURKEY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 207 TURKEY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 208 TURKEY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 209 TURKEY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 210 TURKEY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 211 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 212 HUNGARY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 213 HUNGARY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 214 HUNGARY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 215 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 216 HUNGARY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 217 HUNGARY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 218 HUNGARY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 219 HUNGARY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 220 HUNGARY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 221 HUNGARY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 222 HUNGARY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 223 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 224 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 225 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 226 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 227 AUSTRIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 228 AUSTRIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 229 AUSTRIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 230 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 231 AUSTRIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 232 AUSTRIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 233 AUSTRIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 234 AUSTRIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 235 AUSTRIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 236 AUSTRIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 237 AUSTRIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 238 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 239 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 240 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 241 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 242 LITHUANIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 243 LITHUANIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 244 LITHUANIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 245 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 246 LITHUANIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 247 LITHUANIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 248 LITHUANIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 249 LITHUANIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 250 LITHUANIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 251 LITHUANIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 252 LITHUANIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 253 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 254 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 255 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 256 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 257 NETHERLANDS INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 258 NETHERLANDS SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 259 NETHERLANDS NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 260 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 261 NETHERLANDS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 262 NETHERLANDS MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 263 NETHERLANDS SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 264 NETHERLANDS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 265 NETHERLANDS ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 266 NETHERLANDS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 267 NETHERLANDS BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 268 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 269 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 270 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 271 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 272 SWITZERLAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 273 SWITZERLAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 274 SWITZERLAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 275 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 276 SWITZERLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 277 SWITZERLAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 278 SWITZERLAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 279 SWITZERLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 280 SWITZERLAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 281 SWITZERLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 282 SWITZERLAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 283 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 284 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 285 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 286 REST OF EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

그림 목록

LIST OF FIGURES

FIGURE 1 EUROPE SLEEP DISORDER TREATMENT MARKET: SEGMENTATION

FIGURE 2 EUROPE SLEEP DISORDER TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE SLEEP DISORDER TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 EUROPE SLEEP DISORDER TREATMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE SLEEP DISORDER TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE SLEEP DISORDER TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE SLEEP DISORDER TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE SLEEP DISORDER TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 EUROPE SLEEP DISORDER TREATMENT MARKET: MARKET END USER COVERAGE GRID

FIGURE 10 EUROPE SLEEP DISORDER TREATMENT MARKET: SEGMENTATION

FIGURE 11 RISING PREVALENCE OF SLEEPING DISORDERS IS EXPECTED TO DRIVE THE EUROPE SLEEP DISORDER TREATMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 INSOMNIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SLEEP DISORDER TREATMENT MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE SLEEP DISORDER TREATMENT MARKET

FIGURE 14 PROPORTION OF AMERICAN TWEENS (8- TO 12- YEAR-OLD) SPENDING TIME WITH SCREEN MEDIA IN A DAY (IN HOURS)

FIGURE 15 PROPORTION OF AMERICAN TEENS (13- TO 18- YEAR-OLD) SPENDING TIME WITH SCREEN MEDIA IN A DAY (IN HOURS)

FIGURE 16 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE, 2020

FIGURE 17 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE, 2020-2028 (USD MILLION)

FIGURE 18 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE, CAGR (2020-2028)

FIGURE 19 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 20 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, 2020

FIGURE 21 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, 2020-2028 (USD MILLION)

FIGURE 22 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, CAGR (2020-2028)

FIGURE 23 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, LIFELINE CURVE

FIGURE 24 EUROPE SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020

FIGURE 25 EUROPE SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)

FIGURE 26 EUROPE SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)

FIGURE 27 EUROPE SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 28 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, 2020

FIGURE 29 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, 2020-2028 (USD MILLION)

FIGURE 30 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, CAGR (2020-2028)

FIGURE 31 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, LIFELINE CURVE

FIGURE 32 EUROPE SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, 2020

FIGURE 33 EUROPE SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, 2020-2028 (USD MILLION)

FIGURE 34 EUROPE SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, CAGR (2020-2028)

FIGURE 35 EUROPE SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, LIFELINE CURVE

FIGURE 36 EUROPE SLEEP DISORDER TREATMENT MARKET: BY END USER, 2020

FIGURE 37 EUROPE SLEEP DISORDER TREATMENT MARKET: BY END USER, 2020-2028 (USD MILLION)

FIGURE 38 EUROPE SLEEP DISORDER TREATMENT MARKET: BY END USER, CAGR (2020-2028)

FIGURE 39 EUROPE SLEEP DISORDER TREATMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 41 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)

FIGURE 42 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)

FIGURE 43 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 EUROPE SLEEP DISORDER TREATMENT MARKET: SNAPSHOT (2020)

FIGURE 45 EUROPE SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020)

FIGURE 46 EUROPE SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 47 EUROPE SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 48 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE (2020-2028)

FIGURE 49 EUROPE SLEEP DISORDER TREATMENT MARKET: COMPANY SHARE 2020 (%)

자세한 정보 보기

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.